Net selling: insiders sold $26.4M and bought $0 on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsEach bar is 100% of that source’s money. The notch marks an even split.
Lean is the direction of the latest moves. Descriptive, not advice.
Buys/Adds (2)
Citadel
$209.6M
added
Millennium
$35.2M
added
Sells/Trims (1)
Squarepoint
$29.3M
trimmed
No tracked top-trader positions in EHC as of Oct 21, 16:27 UTC.
Hyperliquid positioning - not every stock is covered
Last report
Aug 5, 2026
Period ending
Jun 30, 2026
Earnings per share
$1.48 expected
Revenue
Financial statements: Alpha Vantage
Estimates as of Oct 21, 2026
EPS expected
$1.25 to $1.41
Revenue expected
11 analysts
Last 30 days
Analysts raising estimates
| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / income | Surprise |
|---|---|---|---|---|---|
| Jun 30, 2026 | Aug 5, 2026 | $1.55 / $1.48Yahoo Finance | +4.75% beat | $1.60B No estimate | Unavailable |
| Mar 31, 2026 | Apr 30, 2026 | $1.60 / $1.49Yahoo Finance | +7.09% beat | $1.59B No estimate | Unavailable |
| Dec 31, 2025 | Feb 5, 2026 | $1.46 / $1.30Yahoo Finance | +12.14% beat | $1.54B No estimate | Unavailable |
| Sep 30, 2025 | Oct 29, 2025 | $1.23 / $1.19Yahoo Finance | +3.20% beat | $1.48B No estimate | Unavailable |
| Jun 30, 2025 | Aug 4, 2025 | $1.40 / $1.21Alpha Vantage | +15.70% beat | $1.46B No estimate | Unavailable |
| Mar 31, 2025 | Apr 24, 2025 | $1.37 / $1.19Alpha Vantage | +15.13% beat | $1.46B No estimate | Unavailable |
| Dec 31, 2024 | Feb 6, 2025 | $1.17 / $1.02Alpha Vantage | +14.71% beat | $1.41B No estimate | Unavailable |
| Sep 30, 2024 | Oct 28, 2024 | $1.03 / $0.94Alpha Vantage | +9.57% beat | $1.35B No estimate | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue and income use company releases, SEC filings, Alpha Vantage or Yahoo Finance. Non-USD revenue carries its currency code. Comparisons require a paired release estimate.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $1.48B | $1.54B | $1.59B | $1.60B |
| Cost of what it sold | $849.4M | $865.6M | $882.4M | $886.4M |
| Gross profit | $628.1M | $679.0M | $704.2M | $711.0M |
| What it spent | ||||
| Sales and admin | $71.0M | $82.9M | $73.4M | $77.3M |
| Other operating costs | $313.5M | $312.7M | $329.2M | $345.3M |
| Total operating expenses | $384.5M | $395.6M | $402.6M | $422.6M |
| What was left | ||||
| Operating profit | $243.6M | $283.4M | $301.6M | $288.4M |
| Interest on debt | $30.8M | $30.2M | $31.8M | $32.8M |
| Profit before tax | $219.9M | $257.7M | $288.7M | $261.6M |
| Tax | $44.9M | $55.4M | $56.4M | $53.6M |
| Net profit | $126.5M | $146.1M | $194.5M | $153.9M |
| EBITDA | $333.1M | $374.3M | $407.8M | $384.8M |
This stock's price action is mixed.
Trend
Mixed
40 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
Coverage is bullish
Encompass Health Corp. R (HSOA.DE) recent insider transactions
NeutralOct 16Encompass Health stock hits 52-week high at 129.34 USD
BullishOct 15Encompass Health stock hits 52-week high at 129.34 USD By Investing.com
NeutralOct 15Full Transcript: Encompass Health Q2 2026 Earnings Call
BullishOct 13Encompass Health Corp. R (HSOA.DE) company profile and facts
NeutralOct 8Encompass Health Corporation (EHC) Stock Forecasts
BullishOct 8Encompass Health Rehabilitation Hospital of Bangor now open in Maine
BullishOct 6A Maine rehab hospital is taking patients. It’s Encompass Health’s first wholly owned hospital in the state.
BullishOct 6